Amber Tilley
Family · Marshall, ARNPI 1790058709
Payments from drug & device makers
Across 275 payments — averaging $16.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$705
- Pfizer$517
- GSK$459
- AstraZeneca$350
- Novo Nordisk$341
- Lilly USA, LLC$245
- plus $2K from 32 others
What the payments were for
- Food & beverage$4,470100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 59 | $705 |
| Pfizer | 29 | $517 |
| GSK | 31 | $459 |
| AstraZeneca | 19 | $350 |
| Novo Nordisk | 21 | $341 |
| Lilly USA, LLC | 15 | $245 |
| Otsuka America Pharmaceutical, Inc. | 9 | $186 |
| Johnson & Johnson | 10 | $181 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 8 | $137 |
| Lundbeck LLC | 8 | $133 |
| Corcept Therapeutics | 5 | $125 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 7 | $119 |
| Corium, LLC | 4 | $105 |
| Amgen(2 entities) | 4 | $70 |
| Novartis | 4 | $63 |
| Teva Pharmaceuticals USA, Inc. | 3 | $60 |
| Sunovion Pharmaceuticals Inc. | 4 | $59 |
| Abbott | 3 | $57 |
| Boston Scientific | 2 | $52 |
| Currax Pharmaceuticals LLC | 3 | $50 |
| Biohaven Pharmaceuticals, Inc. | 3 | $49 |
| Phathom Pharmaceuticals, Inc. | 3 | $48 |
| Axsome Therapeutics, Inc. | 2 | $45 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $41 |
| Nevro Corp. | 2 | $34 |
| Boehringer Ingelheim | 2 | $31 |
| Acadia Pharmaceuticals Inc | 1 | $26 |
| Idorsia Pharmaceuticals US Inc | 2 | $25 |
| Ultragenyx Pharmaceutical Inc. | 1 | $20 |
| Eisai Inc. | 1 | $19 |
| Kowa Pharmaceuticals America, Inc. | 1 | $19 |
| Genentech USA, Inc. | 1 | $16 |
| Dexcom, Inc. | 1 | $16 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $16 |
| Bayer | 1 | $14 |
| Astellas Pharma US Inc | 1 | $13 |
| Ironwood Pharmaceuticals, Inc | 1 | $12 |
| Merck | 1 | $11 |
How this compares
$4,470 in reported general payments places this provider in the 90th percentile of 2,103 family providers in Arkansas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 73 | $73,220 |
| JardianceEmpagliflozin | 48 | $24,435 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 19 | $17,306 |
| JanuviaSitagliptin Phosphate | 20 | $12,329 |
| EliquisApixaban | 12 | $7,015 |
| SynthroidLevothyroxine Sodium | 11 | $956 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 33 | $916 |
| Pravastatin Sodium | 38 | $779 |
| Atorvastatin Calcium | 106 | $611 |
| Fluticasone Propionate | 51 | $524 |
| Omeprazole | 32 | $518 |
| Levothyroxine Sodium | 88 | $439 |
| Gabapentin | 25 | $403 |
| Famotidine | 56 | $390 |
| Pantoprazole Sodium | 38 | $365 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $341 | $73,22073 claims |
| Boehringer IngelheimJardiance | $31 | $24,43548 claims |
| GSKTrelegy Ellipta | $459 | $17,30619 claims |
| MerckJanuvia | $11 | $12,32920 claims |
| PfizerEliquis | $517 | $7,01512 claims |
| AbbVieSynthroid | $705 | $95611 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,103 family providers in Arkansas.
Other family in Marshall
- Leah CarringtonRogers$1.6M
- Nina CopelandFort Smith$207K
- Stefanie BrackinJonesboro$51K
- Amanda DavisFort Smith$46K
- Allison HittManila$40K
- Kimberly GatesNorth Little Rock$31K
- Meghan MallettConway$25K
- Anthony EcholsLittle Rock$25K
- Shelby CochranFayetteville$23K
- Michael StirlingLittle Rock$23K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.